Clinical trials are slowed by fragmented data, manual patient matching, and underrepresentation of diverse populations.
R&D Focus
AI-assisted target discovery and drug development
Innovative Solution
Guilford Street Laboratories offers precise biomarker assays using machine learning-driven mass spectrometry for protein, lipid, and metabolite markers.
Investment Funding
Last Funding Stage
Pre-Seed
Last Funding Date
17-05-2024
Startup Stage
Seed
Lead Investors
GS Verde Group
About
Guilford Street Laboratories offers precise biomarker assays using machine learning-driven mass spectrometry for protein, lipid, and metabolite markers. Their services are crucial for early disease diagnosis, drug discovery, EU Horizon consortium collaboration, clinical trials, and personalized medicine.
Products
Demo Product or Complete Product?
Clinical-stage
Something missing or incorrect on this page? Help us enrich this information
